Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data

Human Genomics

Volumn 7, Issue 1, 2013, Pages

  Su, Yuhua ^a   Nielsen, Dahlia ^b   Zhu, Lei ^c   Richards, Kristy ^d   Suter, Steven ^b   Breen, Matthew ^b   Motsinger Reif, Alison ^b   Osborne, Jason ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Homology; Lymphoma; Mixture models

Indexed keywords

ARTICLE; BIVARIATE ANALYSIS; CANCER CLASSIFICATION; CANCER PROGNOSIS; CASE STUDY; CLINICAL RESEARCH; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC SELECTION; GERMINAL CENTER; HUMAN; LARGE CELL LYMPHOMA; NONHUMAN; TUMOR GENE; ALGORITHM; ANIMAL; ANIMAL DISEASE; BIOLOGICAL MODEL; CLASSIFICATION; DNA MICROARRAY; DOG; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; KAPLAN MEIER METHOD; MULTIGENE FAMILY; PATHOLOGY; PROGNOSIS; SPECIES DIFFERENCE; STATISTICAL MODEL;

TUMOR MARKER;

ALGORITHMS; ANIMAL DISEASES; ANIMALS; DOGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOME, HUMAN; HUMANS; KAPLAN-MEIER ESTIMATE; LIKELIHOOD FUNCTIONS; LINEAR MODELS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MODELS, GENETIC; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SPECIES SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84878767367     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-7-2     Document Type: Article

References (39)

1. Lossos I, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R: Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004, 350:1828-1837. (Pubitemid 38917249)
2. Lenz G, Staudt L: Aggressive lymphomas. N Engl J Med 2010, 362:1417-1429.
3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl JMed 1993, 329:987-992.
4. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002, 8:68-74. (Pubitemid 34101731)
5. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lpez-Guillermo A, et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med, 346:1937-1947.
6. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM: Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Nat Acad Sci USA 2008, 105:13520-13525.
7. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, et al.: Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008, 359:2314-2323.
8. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM: A gene expression-basedmethod to diagnose clinically distinct subgroups of diffuse large B-cell lymphoma. Proc Nat Acad Sci USA 2003, 100:9991-9996. (Pubitemid 37087056)
9. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson JJr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511. (Pubitemid 30082188)
10. Eisen M, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Nat Acad Sci USA 1998, 95:14863-14868. (Pubitemid 29003722)
11. Golub T, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
12. Blenk S, Engelmann J, Weniger M, Schultz J, Dittrich M, Rosenwald A, Mller-Hermelink HK, Mller T, Dandekar T: Germinal center B cell-like (GCB) and activated B cell-like (ABC) type diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform 2007, 3:399-420.
13. Smyth G: Linear models and empirical Bayesmethods for assessing differential expression in microarray experiments. Stat Appl GenetMol Biol 2004, 3:3.
14. Sonnhammer E, Koonin E: Orthology, paralogy and proposed classification for paralog subtypes. TIG 2002, 18:619-620. (Pubitemid 35346684)
15. McLachlan G, Basford K: Mixture models: inference and applications to clustering. New York: Marcel Dekker; 1988.
16. McLachlan G, Peel D: Finite mixture models. New York: Wiley; 2000.
17. Efron B: Bootstrap methods: another look at the jackknife. Ann Stat 1979, 7:1-26.
18. Efron B: Better bootstrap confidence intervals. J Am Stat Assoc 1987, 82:171-185.
19. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Edgar R: NCBI GEO: archive for high-throughput functional genomic data. Nucl Acids Res 2009, 37:D885-D890.
20. Lachenbruch P, Mickey M: Estimation of error rates in discriminant analysis. Technometrics 1968, 10:1-11.
21. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995, 57:289-300.
22. MacQueen J: Some methods for classification and analysis of multivariate observations. In Proceedings of Fifth Berkeley Symposium on Math Statistics and Probability. Statistics. Berkeley: 1965 June 21-July 18, Statistical Laboratory of the University of California; 19651:281-297 .
23. SAS: SAS onlineDoc® 9.1.3. (2002-2008) Available at http://support.sas.com/onlinedoc/913.
24. Dempster A, Laird N, Rubin D: Maximum likelihood from incomplete data via the EM algorithm. J Roy Statist Soc Ser B 1977, 39:1-38.
25. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
26. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
27. Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucl Acids Res 2007, 35:D26-D31. (Pubitemid 46056164)
28. Spanevello R, Mazzanti CM, Schmatz R, Thom G, BagatiniM, CorreaM, Rosa C, Stefanello N, Bell LP, Moretto MB, Oliveira L, Morsch VM, Schetinger MR: The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients. Clin Chim Acta 2009, 411:210-214.
29. Behrens T, Kearns GM, Rivard JJ, Bernstein HD, Yewdell JW, Staudt LM: Carboxyl-terminal targeting and novel post-translational processing of JAW1, a lymphoid protein of the endoplasmic reticulum. J Biol Chem 1996, 271:23528-23534. (Pubitemid 26314805)
30. Tedoldi S, Paterson JC, Cordell J, Tan SY, Jones M, Manek S, Dei Tos, A P, Roberton H, Masir N, Natkunam Y, Pileri SA, Facchetti F, Hansmann ML, Mason DY, Marafioti T: Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J Pathol 2006, 209:454-463. (Pubitemid 44194560)
31. Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit, S, Lossos IS, Levy R: The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 2007, 109:1636-1642. (Pubitemid 46239598)
32. Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, Leaderer B, Grulich A, Yeager M, Cozen W, Hoar Zahm, S, Chanock SJ, Rothman N, Hartge P: Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 2009, 18:1259-1270.
33. Durnick D, Law ME, Maurer MJ, Natkunam Y, Levy R, Lossos IS, Kurtin PJ, McPhail ED: Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma. Am J Clin Path 2010, 134:278-281.
34. Han J, Huang NN, Kim DU, Kehrl JH: RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J Leukoc Biol 2006, 79:1357-1367.
35. Banham A, Connors JM, Brown PJ, Cordell JL, Ott G, Sreenivasan G, Farinha P, Horsman DE, Gascoyne RD: Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin Cancer Res 2005, 11:1065-1072. (Pubitemid 40175755)
36. Goatly A, Bacon CM, Nakamura S, Ye H, Kim I, Brown PJ, Ruskon-Fourmestraux A, Cervera P, Streubel B, Banham AH, Du MQ: FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 2008, 21:902-911. (Pubitemid 351896666)
37. Korac P, Dominis, M: Prognosticmarkers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience. Clin Sci 2008, 49:618-624.
38. Nyman H, Jerkeman M, Karjalainen-Lindsberg ML, Banham AH, Leppä S: Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP. Mod Pathol 2009, 22:1094-1101.
39. Tzankov A, Zlobec I, Went P, Robl H, Hoeller S, Dirnhofer S: Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores. Leuk Lymphoma 2010, 21:902-911.